Jpmorgan Chase & CO Bristol Myers Squibb CO Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Jpmorgan Chase & CO holds 74,629,926 shares of BMY stock, worth $3.74 Billion. This represents 0.27% of its overall portfolio holdings.
Number of Shares
74,629,926
Previous 88,814,123
15.97%
Holding current value
$3.74 Billion
Previous $4.82 Billion
35.65%
% of portfolio
0.27%
Previous 0.44%
Shares
13 transactions
Others Institutions Holding BMY
# of Institutions
2,400Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$9.35 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.95 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.58 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$2.96 Billion0.47% of portfolio
-
Capital International Investors Los Angeles, CA55.4MShares$2.78 Billion0.48% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $107B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...